Skip to main content
Have a personal or library account? Click to login
Antineoplastic Drugs as a Potential Risk Factor in Occupational Settings: Mechanisms of Action at the Cell Level, Genotoxic Effects, and Their Detection Using Different Biomarkers Cover

Antineoplastic Drugs as a Potential Risk Factor in Occupational Settings: Mechanisms of Action at the Cell Level, Genotoxic Effects, and Their Detection Using Different Biomarkers

Archives of Industrial Hygiene and Toxicology
Volume 61 (2010): Issue 1 (March 2010)
By: ,  ,   and    
Open Access
|Mar 2010
References

References

  1. National Institute for Occupational Safety and Health (NIOSH). NIOSH Alert. Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Publication Number 2004-165. Cincinatti (OH): NIOSH Publication Dissemination; 2004.
    Search in Google Scholar
  2. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2010 [pristup 17. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  3. Vrhovac B, urednik. Farmakoterapijski priručnik. 4. izd. Zagreb: Medicinska naklada; 2003.
    Search in Google Scholar
  4. International Agency for Research on Cancer (IARC). Complete List of Agents evaluated and their classification [pristup 17. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  5. International Agency for Research on Cancer (IARC). Agents reviewed by the IARC Monographs Volume 1-100A (by CAS numbers) [pristup 17. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  6. International Agency for Research on Cancer (IARC). Summaries and Evaluations: Melphalan, Medphalan and Merphalan [pristup 17. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  7. Falck K, Gröhn P, Sorsa M. Mutagenicity in urine of nurses handling cytostatic drugs.1979;1:1250-1.
    Open DOISearch in Google Scholar
  8. Sanderson BJ, Shield AJ. Mutagenic damage to mammalian cells by therapeutic alkylating agents.1996;355:41-57.
    Open DOISearch in Google Scholar
  9. Sanderson BJ, Ferguson LR, Denny WA. Mutagenic and carcinogenic properties of platinum-based anticencer drugs.1996;355:59-70.
    Open DOISearch in Google Scholar
  10. Jacobson MA, Stack HF, Waters MD. Genetic activity profiles of anticancer drugs.1996;355:171-208.
    Open DOISearch in Google Scholar
  11. Singh B, Gupta RS. Mutagenic responses of thirteen anticancer drugs on mutation induction at multiple genetic loci and sister chromatid exchanges in chinese hamster ovary cells.1983;43:577-84.
    Search in Google Scholar
  12. Page C, Curtis M, Sutter M, Walker M, Hoffman B, urednici. Integrated Pharmacology. 2. izd. Edinburgh: Mosby International Ltd.; 2002.
    Search in Google Scholar
  13. Rang HP, Dale MM, Riffer JM, Moore PK, urednici. Pharmacology. 5. izd. Edinburgh: Churchill Livingstone; 2003.
    Search in Google Scholar
  14. Henke Yarbro C, Hansen Frogge M, Goodman M, urednici. Cancer Nursing: Principles and Practice. 6. izd. Sudbury: Jones and Bartlett Publishers Inc.; 2005.
    Search in Google Scholar
  15. Drabløs F, Feyzi E, Aas PA, Vaagbø CB, Kavli B, Bratlie MS, Peña-Diaz J, Otterlei M, Slupphaug G, Krokan HE. Alkylation damage in DNA and RNA-repair mechanisms and medical significance.2004;3:1389-407.
    Open DOISearch in Google Scholar
  16. Chen C-S, Lin JT, Goss KA, He Y, Halpert JR, Waxman DJ. Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics.2004;65:1278-85.
    Open DOISearch in Google Scholar
  17. Chabner B, Longo DL, urednici. Cancer Chemotherapy and Biotherapy: Principles and Practice. 4. izd. Philadelphia (PA): Lippincot Williams and Wilkins; 2006.
    Search in Google Scholar
  18. Skeel RT, urednik. Handbook of Cancer Chemotherapy. 7. izd. Philadelphia: Lippincot Williams and Wilkins; 2007.
    Search in Google Scholar
  19. Paci A, Rieutord A, Brion F, Prognon P. Separation methods for alkylating antineoplastic compounds.2001;764:255-87.
    Open DOISearch in Google Scholar
  20. British Columbia Cancer Agency (BCCA). BC Cancer Agency Cancer Drug Manual© Gemcitabine [pristup 20. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  21. American Cancer Society, Lenhard RE, Osteen RT, Gansler TS, urednici. Clinical Oncology. 2. izd. Malden (MA): Blackwell Science Inc.; 2001.
    Search in Google Scholar
  22. Schellens JHM, McLeod HL, Newell DR, urednici. Cancer Clinical Pharmacology. New York (NY): Oxford University Press Inc., 2005.
    Search in Google Scholar
  23. Giaccone G, Schilsky R, Sondel P, urednici. Cancer Chemotherapy and Biological Response Modifiers: Annual 19. Amsterdam: Elsevier Science B.V.; 2001.
    Search in Google Scholar
  24. Vig BK. Genetic toxicology of mitomycin C, actinomycins, daunomycin and adriamycin.1977;48:189-238.
    Open DOISearch in Google Scholar
  25. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.1999;57:727-41.
    Open DOISearch in Google Scholar
  26. Vig BK, Lewis R. Genetic toxicology of bleomycin.1978;55:121-45.
    Open DOISearch in Google Scholar
  27. Povirk LF, Austin MJF. Genotoxicity of bleomycin.1991;257:127-43.
    Open DOISearch in Google Scholar
  28. Erexson GL, Bryant MF, Kwanyuen P, Kligerman AD. Bleomycin sulfate-induced micronuclei in human, rat, and mouse peripheral blood lymphocytes.1995;25:31-6.
    Open DOISearch in Google Scholar
  29. González-Cid M, Mudry M, Larripa I. Chromosome damage induced by carboplatin (CBDCA).1995;76:97-103.
    Open DOISearch in Google Scholar
  30. British Columbia Cancer Agency (BCCA). BC Cancer Agency Cancer Drug Manual© Oxaliplatin [pristup 20. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  31. Barton-Burke M, Wilkes GM, Ingwersen K, urednici. Cancer Chemotherapy: A Nursing Process Approach. 3. izd. Sudbury (MA): Jones and Bartlett Publishers, Inc.; 2001.
    Search in Google Scholar
  32. British Columbia Cancer Agency (BCCA). BC Cancer Agency Cancer Drug Manual© Procarbazine [pristup 20. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  33. British Columbia Cancer Agency (BCCA). BC Cancer Agency Cancer Drug Manual© Amsacrine [pristup 20. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  34. Yarbro JW. Mechanism of action of hydroxyurea.1992;19(Suppl 9):1-10.
    Search in Google Scholar
  35. Donehower RC. An overview of the clinical experience with hydroxyurea.1992;19(Suppl 9):11-9.
    Search in Google Scholar
  36. British Columbia Cancer Agency (BCCA). BC Cancer Agency Cancer Drug Manual© Estramustine [pristup 20. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  37. Migliore L, Cocchi R, Scarpato R, Sbrana I. Induction of aneuploidy by the antineoplastic drug estramustine in human lymphocytes.1998;412:33-40.
    Open DOISearch in Google Scholar
  38. Connor TH, McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in health care settings.2006;56:354-65.
    Open DOISearch in Google Scholar
  39. Occupational Safety and Health Administration (OSHA). Office of Occupational Medicine Work Practice Guidelines for Personnel Dealing with Cytotoxic (Antineoplastic) Drugs. Occupational Safety and Health Administration Instruction publication. Washington (DC): US Dept of Labor; 1986.
    Search in Google Scholar
  40. American Society of Health-System Pharmacists. ASHP guidelines on handling hazardous drugs.2006;63:1172-93.
    Open DOISearch in Google Scholar
  41. QuapoS 4: Quality Standard for the Oncology Pharmacy Service With Commentary. 4. izd. Oldenburg: Onkopress; 2009.
    Search in Google Scholar
  42. Turci R, Sottani C, Spagnoli G, Minoia C. Biological and environmental monitoring of hospital personnel exposed to antineoplastic agent: a review of analytical methods.2003;789:169-209.
    Open DOISearch in Google Scholar
  43. World Health Organization (WHO). Biomarkers In Risk Assessment: Validity And Validation. Environmental Health Criteria 222, 2001 [pristup 20. siječnja 2010.]. Dostupno na
    Search in Google Scholar
  44. Norppa H, Sorsa M, Vainio H, Grohn P, Heinonen E, Holsti L, Nordman E. Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs.1980;6:299-301.
    Open DOISearch in Google Scholar
  45. Waksvik H, Klepp O, Brøgger A. Chromosome analyses of nurses handling cytostatic agents.1981;65:607-10.
    Search in Google Scholar
  46. Kolmodin-Hedman B, Hartvig P, Sorsa M, Falck K. Occupational handling of cytostatic drugs.1983;54:25-33.
    Open DOISearch in Google Scholar
  47. Stiller A, Obe G, Boll I, Pribilla W. No elevation of the frequencies of chromosomal alterations as a consequence of handling cytostatic drugs: Analyses with peripheral blood and urine of hospital personnel.1983;121:253-9.
    Open DOISearch in Google Scholar
  48. Barale R, Sozzi G, Toniolo P, Borghi O, Reali D, Loprieno N, Della Porta G. Sister-chromatid exchanges in lymphocytes and mutagenicity in urine of nurses handling cytostatic drugs.1985;157:235-40.
    Open DOISearch in Google Scholar
  49. Jordan DK, Patil SR, Jochimsen PR, Lachenbruch PA, Corder MP. Sister chromatid exchange analysis in nurses handling antineoplastic drugs.1986;4:101-7.
    Open DOISearch in Google Scholar
  50. Pohlová H, Černá M, Rössner P. Chromosomal aberrations, SCE and urine mutagenicity in workers occupationally exposed to cytostatic drugs.1986;174:213-7.
    Open DOISearch in Google Scholar
  51. Stücker I, Hirsch A, Doloy T, Bastie-Sigeac I, Hémon D. Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs.1986;57:195-205.
    Open DOISearch in Google Scholar
  52. Benhamou S, Pot-Deprun J, Sancho-Garnier H, Chouroulinkov I. Sister-chromatid exchanges and chromosomal aberrations in lymphocytes of nurses handling cytostatic agents.1988;41:350-3.
    Open DOISearch in Google Scholar
  53. Sorsa M, Pyy L, Salomaa S, Nyland L, Yager JW. Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals.1988;204:465-79.
    Open DOISearch in Google Scholar
  54. Krepinsky A, Bryant DW, Davison L, Heddle J, McCalla DR, Douglas G, Michalko K. Comparison of three assays for genetic effects of antineoplastic drugs on cancer patients and their nurses.1990;15:83-92.
    Open DOISearch in Google Scholar
  55. Oestreicher U, Stephan G, Glatzel M. Chromosome and SCE analysis in peripheral lymphocytes of persons occupationally exposed to cytostatic drugs handled with and without use of safety covers.1990;242:271-7.
    Open DOISearch in Google Scholar
  56. Sarto F, Trevisan A, Tomanin R, Canova A, Fiorentino M. Chromosomal aberrations, sister chromatid exchanges and urinary thioethers in nurses handling antineoplastic drugs.1990;18:689-95.
    Open DOISearch in Google Scholar
  57. Guinee EP, Beuman GH, Hageman G, Welle IJ, Kleinjans JC. Evaluation of genotoxic risk of handling cytostatic drugs in clinical pharmacy practice.1991;13:78-82.
    Open DOISearch in Google Scholar
  58. Milković-Kraus S, Horvat Đ. Chromosomal abnormalities among nurses occupationally exposed to antineoplastic drugs.1991;19:771-4.
    Open DOISearch in Google Scholar
  59. Thiringer G, Granung G, Holmén A, Hogstedt B, Jarvhom B, Jonsson D, Persson L, Wahlstrom J, Westin J. Comparison of methods for the biomonitoring of nurses handling antitumor drugs.1991;17:133-8.
    Open DOISearch in Google Scholar
  60. Şardaş S, Gök, S, Karakaya AE. Sister chromatid exchanges in lymphocytes of nurses handling antineoplastic drugs.1991;55:311-5.
    Open DOISearch in Google Scholar
  61. Goloni-Bertollo EM, Tajara EH, Manzato AJ, Varella-Garcia M. Sister chromatid exchanges and chromosome aberrations in lymphocytes of nurses handling antineoplastic drugs.1992;50:341-4.
    Open DOISearch in Google Scholar
  62. McDiarmid MA, Kolodner K, Humphrey F, Putman D, Jacobson-Kram D. Baseline and phosphoramide mustard-induced sister-chromatid exchanges in pharmacists handling anti-cancer drugs.1992;279:199-204.
    Open DOISearch in Google Scholar
  63. Gorecka D, Gorski T. The influence of cigarette smoking on sister chromatid exchange frequencies in peripheral lymphocytes among nurses handling cytostatic drugs.1993;6:143-8.
    Search in Google Scholar
  64. Roth S, Norppa H, Järventaus H, Kyyrönen P, Ahonen M, Lehtomäki J, Sainio H, Sorsa M. Analysis of chromosomal aberrations, sister chromatid exchanges and micronuclei in peripheral lymphocytes of pharmacists before and after working with cytostatic drugs.1994;325:157-62.
    Open DOISearch in Google Scholar
  65. Peschke M, Nagel S, Haamann F, Melzer S, Meier K. Cytogenetic monitoring of pharmaceutical staff working with cytostatic drug preparations: A 5-year follow-up.1995;1:33-9.
    Open DOISearch in Google Scholar
  66. Thulin H, Sundberg E, Hansson K, Cole J, Hartley-Asp B. Occupational exposure to nor-nitrogen mustard: Chemical and biological monitoring.1995;11:89-97.
    Open DOISearch in Google Scholar
  67. Brumen V, Horvat Đ. Work environment influence on cytostatics-induced genotoxicity in oncologic nurses.1996;30:67-71.
    Open DOISearch in Google Scholar
  68. Ensslin AS, Huber R, Pethran A, Rommelt H, Schierl R, Kulka U, Fruhmann G. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetic studies.1997;70:205-8.
    Open DOISearch in Google Scholar
  69. Fučić A, Jazbec A, Mijić A, Šešo-Šimić Đ, Tomek R. Cytogenetic consequences after occupational exposure to antineoplastic drugs.1998;416:59-66.
    Open DOISearch in Google Scholar
  70. Kevekordes S, Gebel TW, Hellwig M, Dames W, Dunkelberg H. Human effect monitoring in cases of occupational exposure to antineoplastic drugs: A method comparison.1998;55:145-9.
    Open DOISearch in Google Scholar
  71. Mahrous HS, Ismail SR, Hashishe MM, Kohail HM. Sister chromatid exchanges and chromosome aberrations in lymphocytes of medical personnel handling cytostatic drugs.1998;73:297-323.
    Search in Google Scholar
  72. Kašuba V, Rozgaj R, Garaj-Vrhovac V. Analysis of sister chromatid exchange and micronuclei in peripheral blood lymphocytes of murses handling cytostatic drugs.1999;19:401-4.
    Open DOISearch in Google Scholar
  73. Lanza A, Robustelli della Cuna FS, Zibera C, Pedrazzoli P, Robustelli della Cuna G. Somatic mutations at the T-cell antigen receptor in antineoplastic drug-exposed populations: comparison with sister chromatid exchange frequency.1999;72:315-22.
    Open DOISearch in Google Scholar
  74. Pilger A, Kohler I, Stettner H, Mader RM, Rizovski B, Terkola R, Diem E, Franz-Hainzl E, Konnaris C, Valic E, Rudiger HV. Long-term monitoring of sister chromatid exchanges and micronucleus formation in pharmacy personnel occupationally exposed to cytostatic drugs.2000;73:442-8.
    Open DOISearch in Google Scholar
  75. Jakab MG, Major J, Tompa A. Follow-up genotoxicological monitoring of nurses handling antineoplastic drugs.2001;62:307-18.
    Open DOISearch in Google Scholar
  76. Tompa A, Jakab M, Biro A, Magyar B, Fodor Z, Klupp T, Major J. Chemical Safety and Health Conditions among Hungarian Hospital Nurses.2006;1076:635-48.
    Open DOISearch in Google Scholar
  77. Ikeda K, Yagi Y, Tkegami M, Lu Y, Morimoto K, Kurokawa N. Efforts to ensure safety of hospital pharmacy personnel occupationally exposed to antineoplastic drugs during a preparation task.2007;42:209-18.
    Open DOISearch in Google Scholar
  78. Kopjar N, Kašuba V, Rozgaj R, Želježić D, Milić M, Ramić S, Pavlica V, Milković-Kraus S. The genotoxic risk in health care workers occupationally exposed to cytotoxic drugs - A comprehensive evaluation by the SCE assay.2009;44:462-79.
    Open DOISearch in Google Scholar
  79. Kopjar N, Garaj-Vrhovac V, Kašuba V, Rozgaj R, Ramić S, Pavlica V, Želježić D. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: A multi-biomarker approach.2009;212:414-31.
    Open DOISearch in Google Scholar
  80. Nikula E, Kiviniitty K, Leisti J, Taskinen PJ. Chromosome aberrations in lymphocytes of nurses handling cytostatic agents.1984;10:71-4.
    Open DOISearch in Google Scholar
  81. Rössner P, Černá M, Pokorána D, Hájek V, Petr J. Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations, urine mutagenicity and nucleolus test in workers occupationally exposed to cytostatic drugs.1988;208:149-53.
    Open DOISearch in Google Scholar
  82. Medkova J. Cytogenetic analysis of peripheral lymphocytes in occupationally exposed health personnel.1990;126:93-106.
    Search in Google Scholar
  83. Cooke J, Williams J, Morgan RJ, Cooke P, Calvert RT. Use of cytogenetic methods to determine mutagenic changes in the blood of pharmacy personnel and nurses who handle cytotoxic agents.1991;48:1199-205.
    Open DOISearch in Google Scholar
  84. Milković-Kraus S, Kraus O, Kršnjavi H, Kubelka D. Environmental effects on chromosomes in oncology and radiology department personnel.1992;21:498-502.
    Open DOISearch in Google Scholar
  85. Grummt T, Grummt H-J, Schott G. Chromosomal aberrations in peripheral lymphocytes of nurses and physicians handling antineoplastic drugs.1993;302:19-24.
    Open DOISearch in Google Scholar
  86. Anwar WA, Salama SI, Serafy MM, Hermida S, Hafez AS. Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs.1994;9:315-7.
    Open DOISearch in Google Scholar
  87. Sessink PJM, Cerná M, Rössner P, Pastorkova A, Bavarova H, Frankova K, Anzion RB, Bos RP. Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents.1994;309:193-9.
    Open DOISearch in Google Scholar
  88. Rubeš J, Kucharová S, Vozdová M, Musilová P, Zudová Z. Cytogenetic analysis of peripheral lymphocytes in medical personnel by means of FISH.1998;412:293-8.
    Open DOISearch in Google Scholar
  89. Ansari-Lari M, Saadat M, Shahryari M, Farhud DD. Sister Chromatid Exchanges and Micronuclei in Lymphocyte of Nurses Handling Antineoplastic Drug.2001;30:37-40.
    Search in Google Scholar
  90. Burgaz S, Karahalil B, Canhi Z, Terzioglu F, Ancel G, Anzion RB, Bos RP, Huttner E. Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations.2002;21:129-35.
    Open DOISearch in Google Scholar
  91. Xu SJ Wang JX Yang DP. [An investigation on the chromosomal damage in nurses occupationally exposed to antineoplastic drugs, in Chinese].2003;37:119-20.
    Search in Google Scholar
  92. Domínguez Odio A, Batista Duharte A, Carnesoltas D, Romero García LI, Lóriega Loaces E, Cuello Almarales D, Landrove Mora Y, García Cabrera L. Efectos citogenéticos por exposición ocupacional a citostáticos [Cytogenetic effects after occupational exposure to cytostatics, in Spanish].2004;42:487-92.
    Search in Google Scholar
  93. Cavallo D, Ursini CL, Perniconi B, Di Francesco A, Giglio M, Rubino FM, Marinaccio A, Iavicoli S. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees.2005;587:45-51.
    Open DOISearch in Google Scholar
  94. Testa A, Giachelia M, Palma S, Appolloni M, Padua L, Tranfo G, Spagnoli M, Trindelli D, Cozzi R. Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms.2007;223:46-55.
    Open DOISearch in Google Scholar
  95. Mušák L, Poláková V, Halašová E, Osina O, Vodičková L, Buchancová J, Hudečková H, Vodička P. Effect of occupational exposure to cytostatics and nucleotide excision repair polymorphism on chromosomal aberrations frequency.2009;2:13-7.
    Open DOISearch in Google Scholar
  96. Yager JW, Sorsa M, Selvin S. Micronuclei in cytokinesis-blocked lymphocytes as an index of occupational exposure to alkylating cytostatic drugs.1988;89:213-6.
    Search in Google Scholar
  97. Machado-Santelli GM, Cerqueira EM, Oliveira CT, de Braganca Peira CAA. Biomonitoring of nurses handling antineoplastic drugs.1994;332:203-8.
    Open DOISearch in Google Scholar
  98. Garaj-Vrhovac V, Kopjar N. Micronuclei in cytokinesis-blocked lymphocytes as an index of occupational exposure to antineoplastic drugs.1998;32:385-92.
    Search in Google Scholar
  99. Burgaz S, Karahalil B, Bayrak P, Taşkin L, Yavuzaslan F, Bökesoy I, Anzion RBM, Bos RP, Platin N. Urinary cyclophosphamide excretion and micronuclei frequencies in periperal lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics.1999;439:97-104.
    Open DOISearch in Google Scholar
  100. Maluf SW, Erdtmann B. Evaluation of occupational genotoxic risk in a Brazilian hospital.2000;23:485-8.
    Open DOISearch in Google Scholar
  101. Maluf SW, Erdtmann B. Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis assay.2000;471:21-7.
    Open DOISearch in Google Scholar
  102. Hessel H, Radon K, Pethran A, Maisch B, Grobmair S, Sautter I, Fruhmann G. The genotoxic risk of hospital, pharmacy and medical personnel occupationally exposed to cytostatic drugs-evaluation by the micronucleus assay.2001;497:101-9.
    Open DOISearch in Google Scholar
  103. Deng H, Zhang M, He J, Wu W, Jin L, Zheng W, Lou J, Wang B. Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points.2005;20:351-7.
    Open DOISearch in Google Scholar
  104. Deng H, Lou J, Zhang M, Wu W, Jin L, Chen S, Zheng W, Wang B, He J. Detecting the cytogenetic effects in workers occupationally exposed to vincristine with four genetic tests.2006;599:152-9.
    Open DOISearch in Google Scholar
  105. Laffon B, Teixeira JP, Silva S, Loureiro J, Torres J, Pásaro E, Méndez J, Mayan O. Genotoxic effects in a population of nurses handling antineoplastic drugs, and relationship with genetic polymorphisms in DNA repair enzymes.2006;48:128-36.
    Open DOISearch in Google Scholar
  106. Cavallo D, Ursini CL, Omodeo-Sale E, Iavicoli S. Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses handling antineoplastic drugs.2007;628:11-8.
    Open DOISearch in Google Scholar
  107. Rekhadevi PV, Sailaja N, Chandrasekhar M, Mahboob M, Rahman MF, Grover P. Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.2007;22:395-401.
    Open DOISearch in Google Scholar
  108. Cornetta T, Padua L, Testa A, Ievoli E, Festa F, Tranfo G, Baccelliere L, Cozzi R. Molecular biomonitoring of a population of nurses handling antineoplastic drugs.2008;638:75-82.
    Open DOISearch in Google Scholar
  109. Rombaldi F, Cassini C, Salvador M, Saffi J, Erdtmann B. Occupational risk assessment of genotoxicity and oxidative stress in workers handling anti-neoplastic drugs during a working week.2009;24:143-8.
    Open DOISearch in Google Scholar
  110. Ündeger Ü, Basaran N, Kars A, Guc D. Assessment of DNA damage in nurses handling antineoplastic drugs by the alkaline COMET assay.1999;439:277-85.
    Open DOISearch in Google Scholar
  111. Kopjar N, Garaj-Vrhovac V. Application of the alkaline comet assay in human biomonitoring for genotoxicity: A study on Croatian medical personnel handling antineoplastic drugs.2001;16:71-8.
    Open DOISearch in Google Scholar
  112. Yang D, Xu S, Wang J. [The study of DNA damage of peripheral lymphocytes in the nurses occupationally exposed to anticancer drugs, in Chinese].2002;20:197-9.
    Search in Google Scholar
  113. Ursini CL, Cavallo D, Colombi A, Giglio M, Marinaccio A, Iavicoli S. Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs.2006;80:134-40.
    Open DOISearch in Google Scholar
  114. Yoshida J, Kosaka H, Tomioka K, Kumagai S. Genotoxic risks to nurses from contamination of the work environment with antineoplastic drugs in Japan.2006;48:517-22.
    Open DOISearch in Google Scholar
  115. Sasaki M, Dakeishi M, Hoshi S, Ishii N, Murata K. Assessment of DNA damage in Japanese nurses handling antineoplastic drugs by the comet assay.2008;50:7-12.
    Open DOISearch in Google Scholar
  116. Izdes S, Sardas S, Kadioglu E, Kaymak C, Ozcagli E. Assessment of Genotoxic damage in nurses occupationally exposed to anaesthetic gases or antineoplastic drugs by the comet assay.2009;51:283-6.
    Open DOISearch in Google Scholar
  117. Perry P, Wolff S. New Giemsa method for the differential staining of sister chromatids.1974;251:156-8.
    Open DOISearch in Google Scholar
  118. Latt S, Allen J, Bloom SE, Carrano A, Falke E, Kram D, Schneider E, Schreck R, Tice R, Whitfield B, Wollf S. Sister chromatid exchanges: A report of the Gene-Tox Program.1981;87:17-62.
    Open DOISearch in Google Scholar
  119. Carrano AV, Natarajan AT. Considerations for population monitoring using cytogenetic techniques.1988;204:379-406.
    Open DOISearch in Google Scholar
  120. Morimoto K. Induction of sister chromatid exchanges and cell division delays in human lymphocytes by microsomal activation of benzene.1983;43:1330-4.
    Search in Google Scholar
  121. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, Natarajan AT, Norppa H, Shuker DEG, Tice R, Waters MD, Aitio A. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans.2000;463:111-72.
    Open DOISearch in Google Scholar
  122. Carrano AV, Moore DH. The rationale and methodology for quantifying sister chromatid exchange in humans. U: Heddle JA, urednik. Mutagenicity: New Horizons in Genetic Toxicology. New York (NY): Academic Press; 1982. str. 267-304.
    Open DOISearch in Google Scholar
  123. Bonassi S, Fontana V, Ceppi M, Barale R, Bigeri A. Analysis of correlated data in human biomonitoring studies. The case of high sister chromatid exchange frequency cells.1999;438:13-21.
    Open DOISearch in Google Scholar
  124. Ponzanelli I, Landi S, Bernacchi F, Barale R. The nature of high frequency sister chromatid exchange cells (HFCs).1997;12:329-33.
    Open DOISearch in Google Scholar
  125. Hirsch BA, Sentz KK, McGue M. Genetic and environmental influences on baseline SCE.1992;20:2-11.
    Open DOISearch in Google Scholar
  126. Lazutka JR, Dedonyte V, Krapavickaite D. Sister-chromatid exchanges and their distribution in human lymphocytes in relation to age, sex and smoking.1994;306:173-80.
    Open DOISearch in Google Scholar
  127. Bolognesi C, Abbondandolo A, Barale R, Casalone R, Dalprà L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Migliore L, Padovani P, Pasquini R, Puntoni R, Sbrana I, Stella M, Bonassi S. Age-ralated increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations and micronuclei in human lymphocytes.1997;6:249-56.
    Search in Google Scholar
  128. Bender MA, Preston J, Leonard RC, Pyatt BE, Gooch PC, Shelby MD. Chromosomal aberration and sister chromatid exchange frequencies in peripheral lymphocytes of a large human population sample.1988;204:421-33.
    Open DOISearch in Google Scholar
  129. Anderson D, Francis AJ, Godbert P, Jenkinson PC, Butterworth KR. Variability in chromosome aberrations, sister chromatid exchanges, and mitogen-induced blastogenesis in peripheral lymphocytes from control individuals.1993;101(Suppl 3):83-8.
    Open DOISearch in Google Scholar
  130. Sharma T, Das BC. Higher incidence of spontaneous sister-chromatid exchanges (SCEs) and X-ray-induced chromosome aberrations in peripheral blood lymphocytes during pregnancy.1986;174:27-33.
    Open DOISearch in Google Scholar
  131. Vijayalaxmi, Evans HJ.andeffects of cigarette smoke on chromosomal damage and sister chromatid exchange in human peripheral blood lymphocytes.1982;92:321-32.
    Open DOISearch in Google Scholar
  132. Obe G, Vogt HJ, Madle S, Fahning A, Heller WD. Doubleblind study on the effect of cigarette smoking on the chromosomes of human peripheral blood lymphocytes1982;92:309-19.
    Open DOISearch in Google Scholar
  133. Tucker JD, Ashworth LK, Johnston GR, Allen NA, Carrano AV. Variation in human lymphocyte sister-chromatid exchange frequency: result of a long-term longitudinal study.1988;204:435-44.
    Open DOISearch in Google Scholar
  134. Reidy JA, Annest JL, Chen ATL, Welty TK. Increased sister chromatid exchange associated with smoking and coffee consumption.1988;12:311-8.
    Open DOISearch in Google Scholar
  135. Bonassi S, Bolognesi C, Abbondandolo A, Barale R, Bigatti P, Camurri L, Dalprà L, De Ferrari M, Forni A, Lando C, Padovani P, Pasquini R, Stella M, Puntoni R. Influence of sex on cytogenetic end points - evidence from a large human sample and review of the literature.1995;4:671-9.
    Search in Google Scholar
  136. Slapšyte G, Jankauskiene A, Mieraiskiene J, Lazutka JR. Cytogenetic analysis of peripheral blood lymphocytes of children treated with nitrofurantion for recurrent urinary tract infection.2002;17:31-5.
    Open DOISearch in Google Scholar
  137. Gutierrez S, Carbonell E, Galofre P, Creus A, Marcos R. Low sensitivity of the sister chromatid exchange assay to detect the genotoxic effects of radioiodine therapy.1999;14:221-6.
    Open DOISearch in Google Scholar
  138. Jacobson-Kram D. The effects of diagnostic ultrasound on sister chromatid exchange frequencies: a review of the recent literature.1984;12:5-10.
    Open DOISearch in Google Scholar
  139. Garaj-Vrhovac V, Kopjar N. Cytogenetic monitoring of cardiology unit hospital workers exposed to ultrasound.2000;20:259-64.
    Open DOISearch in Google Scholar
  140. Atalay F, Baltaci V, Alpas I, Savas I, Atikcan S, Balci S. Sister chromatid exchange rate from pleural fluid cells in patient with malignant mesothelioma.2000;465:159-63.
    Open DOISearch in Google Scholar
  141. Cortes-Guttierez EI, Cerda-Flores RM, Leal-Garza CH. Sister chromatid exchanges in peripheral lymphocytes from women with carcinoma of the uterine cervix.2000;122:121-3.
    Open DOISearch in Google Scholar
  142. Cottliar A, Fundia A, Boerr L, Sambuelli A, Negreira S, Gil A, Gomez JC, Chopita N, Bernedo A, Slavutsky I. High frequencies of telomeric associations, chromosome aberrations, and sister chromatid exchanges in ulcerative colitis.2000;95:2301-7.
    Open DOISearch in Google Scholar
  143. Carbonell E, Demopoulos NA, Stefanou G, Psaraki K, Parry EM, Marcos R. Cytogenetic analysis in peripheral lymphocytes of cancer patients treated with cytostatic drugs: Results from an EC Collaborative Study.1996;7:514-9.
    Open DOISearch in Google Scholar
  144. Kopjar N, Milas I, Garaj-Vrhovac V, Gamulin M. Cytogenetic outcomes of adjuvant chemotherapy in non-target cells of breast cancer patients.2007;26:391-9.
    Open DOISearch in Google Scholar
  145. Norppa H, Bonassi S, Hansteen I-L, Hagmar L, Strömberg U, Rössner P, Boffeta P, Lindholm C, Gundy S, Lazutka J, Cebulska-Wasilewska A, Fabianoca E, Šram RJ, Knudsen LE, Barale R, Fučić A. Chromosomal aberrations and SCEs as biomarkers of cancer risk.2006;600:37-45.
    Open DOISearch in Google Scholar
  146. Natarajan AT, Boei JJ, Darroudi F, Van Diemen PCM, Dulout F, Hande MP, Ramalho AT. Current cytogenetic methods for detecting exposure and effects of mutagens and carcinogens.1996;104(Suppl 3):445-8.
    Open DOISearch in Google Scholar
  147. Bender MA, Awa AA, Brooks AL, Evans HJ, Groer PO, Littlefield LG, Pereira C, Preston J, Wachholz BW. Current status of cytogenetic procedures to detect and quantify previous exposure to radiation.1988;196:103-59.
    Open DOISearch in Google Scholar
  148. International Atomic Energy Agency (IAEA). Cytogenetic Analysis for Radiation Dose Assessment. Technical Report Series no. 405. Vienna: IAEA; 2001.
    Search in Google Scholar
  149. Kopjar N, Želježić D, Garaj-Vrhovac V. Evaluation of DNA damage in the white blood cells of healthy human volunteers using the alkaline comet assay and the chromosome aberration test.2006;53:321-36.
    Open DOISearch in Google Scholar
  150. Hagmar L, Bonassi S, Strömberg U, Mikoczy Z, Lando C, Hansten I-L, Huici Montagud A, Knudsen L, Norppa H, Reuterwall C, Tinnerberg H, Brøgger A, Forni A, Högstedt B, Lambert B, Mitelman F, Nordenson I, Salomaa S, Skerfving S. Cancer predictive value of cytogenetic markers used in occupational health surrveilance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health.1998;405:171-8.
    Open DOISearch in Google Scholar
  151. Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures.2003;534:65-75.
    Open DOISearch in Google Scholar
  152. Salama S, Serrana M, Au WW. Biomonitoring using accessible human cells for exposure and health risk assessment.1999;436:99-112.
    Open DOISearch in Google Scholar
  153. Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, Knasmueller S, Fenech M. The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: The HUMN project perspective on current status and knowledge gaps.2008;659:93-108.
    Open DOISearch in Google Scholar
  154. Norppa H, Luomahaara S, Heikanen H, Roth S, Sorsa M, Renzi L, Lindholm C. Micronucleus assay in lymphocytes as a tool to biomonitor human exposure to aneuploidogens and clastogens.1993;101(Suppl 3):139-43.
    Open DOISearch in Google Scholar
  155. Kirsch Volders M, Elhajouji A, Cundari E, Vanhumelen P. Themicronucleus test - a multiendpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction.1997;392:19-30.
    Open DOISearch in Google Scholar
  156. Fenech M, Morley AA. Measurement of micronuclei in lymphocytes.1985;147:29-36.
    Open DOISearch in Google Scholar
  157. Norppa H, Falck GCM. What do human micronuclei contain?2003;18:221-33.
    Open DOISearch in Google Scholar
  158. Schreiber GA, Beisker W, Braselmann H, Bauchinger M, Bögl KW, Nüsse M. Automated flow cytometric micronucleus assay for human lymphocytes.1992;62:695-709.
    Open DOISearch in Google Scholar
  159. Verschaeve L, Vanderkerken M, Kirsch-Volders M. Cbanding as a simple tool to discriminate micronuclei induced by clastogens and aneugens.1988;63:351-4.
    Open DOISearch in Google Scholar
  160. Mateuca R, Lombaert N, Aka PV, Decodier I, Kirsch-Volders M. Chromosomal changes: induction, detection methods and applicability in human biomonitoring.2006;88:1515-31.
    Open DOISearch in Google Scholar
  161. Fenech M. The cytokinesis-block micronucleus technique: A detailed description of the method and its application to genotoxicity studies in human population.1993;285:35-44.
    Open DOISearch in Google Scholar
  162. Fenech M, Neville S, Rinaldi J. Sex is an important variable affecting spontaneous micronucleus frequency in cytokinesisblocked lymphocytes.1994;313:203-7.
    Open DOISearch in Google Scholar
  163. Tucker JD, Nath J, Hando JC. Activation status of the X chromosome in human micronucleated lymphocytes.1996;97:471-5.
    Open DOISearch in Google Scholar
  164. Fenech M, Morley AA. Kinetochore detection in micronuclei: an alternative method for measuring chromosome loss.1989;4:98-104.
    Open DOISearch in Google Scholar
  165. Norppa H, Luomahaara S, Heikanen H, Roth S, Sorsa M, Renzi L, Lindholm C. Micronucleus assay in lymphocytes as a tool to biomonitor human exposure to aneuploidogens and clastogens.1993;101(Suppl 3):139-43.
    Open DOISearch in Google Scholar
  166. Martínez-Pérez LM, Cerda-Flores RM, Gallegos-Cabriales EC, Dávila-Rodríguez MI, Ibarra-Costilla E, Cortés-Gutiérrez EI. Frequency of micronuclei in Mexicans with type 2 diabetes mellitus.2007;108:248-55.
    Search in Google Scholar
  167. Masjedi MR, Heidary A, Mohammadi F, Velayati AA, Dokouhaki P. Chromosomal aberrations and micronuclei in lymphocytes of patients before and after exposure to antituberculosis drugs.2000;15:489-94.
    Open DOISearch in Google Scholar
  168. Milošević-Đorđević O, Grujičić D, Marinković D, Arsenijević S, Banković S. Effect of various doses of gestogens on micronuclei frequency in human peripheral blood lymphocytes of pregnant women.2003;18:433-6.
    Open DOISearch in Google Scholar
  169. Cochran ST, Khodadoust A, Norman A. Cytogenetic effects of contrast material in patients undergoing excretory urography.1980;136:43-6.
    Open DOISearch in Google Scholar
  170. Norman A, Cochran S, Bass D, Roe D. Effects of age, sex and diagnostic X-rays on chromosome damage.1984;46:317-21.
    Open DOISearch in Google Scholar
  171. Larramendy ML, Knuutila S. Increased frequency of micronuclei in B and T8 lymphocytes from smokers.1991;259:189-95.
    Open DOISearch in Google Scholar
  172. Bonassi S, Neri M, Lando C, Ceppi M, Lin Y, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Fenech M. The HUMN collaborative group. Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the Human MicroNucleus project.2003;543:155-66.
    Open DOISearch in Google Scholar
  173. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti P, Bolognesi C, Cebulska-Wasilewska A, Fabianova E, Fučić A, Hagmar L, Joksić G, Martelli A, Migliore L, Mirkova E, Scarfi MR, Zijno A, Norppa H, Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans.2007;28:625-31.
    Open DOISearch in Google Scholar
  174. Rojas E, Lopez MC, Valverde M. Single cell electrophoresis assay: methodology and applications.1999;722:225-54.
    Open DOISearch in Google Scholar
  175. Singh NP. Microgels for estimation of DNA strand breaks, DNA protein crosslinks and apoptosis.2000;455:111-27.
    Open DOISearch in Google Scholar
  176. Plappert U, Raddatz K, Roth S, Fliedner TM. DNA damage detection in man after radiation exposure - the comet assay - its possible application for human monitoring.1995:13:215-22.
    Search in Google Scholar
  177. Singh NP, McCoy MT, Tice RR, Schneider LL. A simple technique for quantitation of low levels of DNA damage in individual cells.1988;175:184-91.
    Open DOISearch in Google Scholar
  178. Olive PL. Applications of the comet assay in radiobiology.1999;75:395-405.
    Open DOISearch in Google Scholar
  179. Collins A, Dušinská M, Gedik C, Štetina R. Oxidative damage to DNA: Do we have a reliable marker?1996;104(Suppl 3):465-9.
    Open DOISearch in Google Scholar
  180. Olive PL, Banath JP, Durand RE. Heterogeneity in radiationinduced DNA damage and repair in tumor and normal cells using the "comet" assay.1990;122:86-94.
    Open DOISearch in Google Scholar
  181. Wojewódzka M, Grądzka I, Buraczewska I. Modified neutral comet assay for human lymphocytes.2002;47:1-5.
    Search in Google Scholar
  182. Pfeiffer P, Goedecke W, Obe G. Mechanisms of DNA double strand break repair and their potential to induce chromosomal aberrations.2000;15:289-302.
    Open DOISearch in Google Scholar
  183. Speit G, Schütz P, Bonzheim I, Trenz K, Hoffmann H. Sensitivity of the FPG protein towards alkylation damage in the comet assay.2004;146:151-8.
    Open DOISearch in Google Scholar
  184. Smith CC, O'Donovan MR, Martin EA. hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII.2006;21:185-90.
    Open DOISearch in Google Scholar
  185. Miyamae Y, Zaizen K, Ohara K, Mine Y, Sasaki YF. Detection of DNA lesions induced by chemical mutagens by the single cell gel electrophoresis (comet) assay. 1. Relationship between the onset of DNA damage and the characteristics of mutagens.1998;415:229-35.
    Open DOISearch in Google Scholar
  186. Tice RR. The single cell gel / comet assay: a microgel electrophoretic technique for the detection of DNA damage and repair in individual cells. U: Phillips DH, Vennit S, urednici. Environmental Mutagenesis. Oxford: Bioscientific; 1995. str. 315-39.
    Search in Google Scholar
  187. Kaminskas E, Li JC. Repair of DNA damage induced by oxygen radicals in human non-proliferating and proliferating lymphocytes.1992;274:103-10.
    Open DOISearch in Google Scholar
  188. Šalagovič J, Maes A, Van Gorp U, Verschaeve L, Kalina I. The cell cycle positions Influence DNA migration as measured with the alkaline comet assay in stimulated human lymphocytes.1997;43:79-82.
    Search in Google Scholar
  189. Villani P, Altavista PL, Castaldi L, Leter G, Cordelli E. Analysis of DNA oxidative damage related to cell proliferation.2000;464:229-37.
    Open DOISearch in Google Scholar
  190. Fortini P, Raspaglio G, Falchi M, Dogliotti E. Analysis of DNA alkylation damage and repair in mammalian cells by the comet assay.1996;11:169-75.
    Open DOISearch in Google Scholar
  191. Betti C, Davini T, Giannessi L, Loprieno N, Barale R. Microgel electrophoresis assay (comet test) and SCE analysis in human lymphocytes from 100 normal subjects.1994;307:323-33.
    Open DOISearch in Google Scholar
  192. Wojewódzka M, Kruszewski M, Iwanenko T, Collins AR, Szumiel I. Application of the comet assay for monitoring DNA damage in workers exposed to chronic low-dose irradiation. I. Strand breakage.1998;416:21-35.
    Open DOISearch in Google Scholar
  193. Mendoza-Núñez VM, Sánchez-Rodríguez MA, Retana-Ugalde R, Vargas-Guadarrama LA, Altamirano-Lozano MA. Total antioxidant levels, gender, and age as risk factors for DNA damage in lymphocytes of the elderly.2001;122:835-47.
    Open DOISearch in Google Scholar
  194. Bajpayee M, Dhawan A, Parmar D, Kumar Pendey A, Mathur N, Seth PK. Gender-related differences in basal DNA damage in lymphocytes of a healthy Indian population using the alkaline comet assay.2002;520:83-91.
    Open DOISearch in Google Scholar
  195. Frenzilli G, Betti C, Davini T, Desideri M, Fornai E, Giannessi L, Maggiorelli F, Paoletti P, Barale R. Evaluation of DNA damage in leukocytes of ex-smokers by single cell gel electrophoresis.1997;375:117-23.
    Open DOISearch in Google Scholar
  196. Zhu CQ, Lam TH, Jiang CQ, Wei BX, Lou X, Liu WW, Lao XQ, Chen YH. Lymphocyte DNA damage in cigarette factory workers measured by the comet assay.1999;444:1-6.
    Open DOISearch in Google Scholar
  197. Singh NP, Danner DB, Tice RR, Pearson JD, Brant LJ, Morrell CH, Schneider EL. Basal DNA damage in individual human lymphocytes with age.1991;256:1-6.
    Open DOISearch in Google Scholar
  198. Piperakis SM, Visvardis EE, Sagnou M, Tassiou AM. Effects of smoking and aging on oxidative DNA damage of human lymphocytes.1998;19:695-8.
    Open DOISearch in Google Scholar
  199. Kopjar N, Želježić D, Garaj-Vrhovac V. Evaluation of DNA damage in the white blood cells of healthy human volunteers using the alkaline comet assay and the chromosome aberration test.2006;53:321-36.
    Open DOISearch in Google Scholar
  200. Hellman B, Friis L, Vaghef H, Edling C. Alkaline single cell gel electrophoresis and human biomonitoring for genotoxicity: a study on subjects with residential exposure to radon.1999;442:121-32.
    Open DOISearch in Google Scholar
  201. Moller P, Wallin H, Holst E, Knudsen LE. Sunlight-induced DNA damage in human mononuclear cells.2002;16:45-53.
    Open DOISearch in Google Scholar
  202. Verschaeve L, Koppen G, Gorp UV, Schoeters G, Jacobs G, Zwijzen C. Seasonal variations in spontaneous levels of DNA damage; implication in the risk assessment of environmental chemicals.2007;27:612-20.
    Open DOISearch in Google Scholar
  203. Gutiérrez S, Carbonell E, Galofré P, Creus A, Marcos R. The alkaline single-cell gel electrophoresis (SCGE) assay applied to the analysis of radiation-induced DNA damage in thyroid cancer patients treated withI.1998;413:111-9.
    Open DOISearch in Google Scholar
  204. Dantas FJ, de Mattos JC, Moraes MO, Boasquevisques E, Rodrigues MP, Lage CA, Cabral-Neto JB, Leitão AC, Bernardo-Filho M, Bezerra RJ, Carvalho JJ, Caldeira-de-Araujo A. DNA damage in peripheral blood nuclear cells assessed by comet assay from individuals submitted to scintigraphic examinations.2002;48:789-91.
    Search in Google Scholar
  205. Biri A, Civelek E, Karahalil B, Sardaş S. Assessment of DNA damage in women using oral contraceptives.2002;521:113-9.
    Open DOISearch in Google Scholar
  206. Milković Đ, Garaj-Vrhovac V, Ranogajec-Komor M, Miljanić S, Gajski G, Knežević Ž, Beck N. Primary DNA damage assessed with the comet assay and comparison to the absorbed dose of diagnostic X-rays in children.2009;5:405-16.
    Open DOISearch in Google Scholar
  207. Mastaloudis A, Yu T-W, O'Donnel RP, Frei B, Dashwood RH, Traber MG. Endurance exercise results in DNA damage as detected by the comet assay.2004;36:966-75.
    Open DOISearch in Google Scholar
  208. Møller P, Knudsen LE, Frentz G, Dybdahl M, Wallin H, Nexø BA. Seasonal variation of DNA damage and repair in patients with non-melanoma skin cancer and referents with and without psoriasis.1998;407:25-34.
    Open DOISearch in Google Scholar
  209. Mozaffarieh M, Schoetzau A, Sauter M, Grieshaber M, Orgül S, Golubnitschaja O, Flammer J. Comet assay analysis of single-stranded DNA breaks in circulating leukocytes of glaucoma patients.2008;14:1584-8.
    Search in Google Scholar
  210. Bilgici B, Bedir A, Şentürk N, Alvur M, Aydin F, Turanli AY. Genotoxicity assessment using comet assay in Behcet's disease patients.2005;578:170-4.
    Open DOISearch in Google Scholar
  211. Hininger I, Chollat-Namy A, Sauvagio S, Osman M, Faure H, Cadet J, Favier A, Rousell A-M. Assessment of DNA damage by comet assay on frozen total blood: method and evaluation in smokers and non-smokers.2004;558:75-80.
    Open DOISearch in Google Scholar
  212. Rapp A, Hausmann M, Greulich KO. The comet-FISH technique: a tool for detection of specific DNA damage and repair.2005;291:107-19.
    Search in Google Scholar
DOI: https://doi.org/10.2478/10004-1254-61-2010-2025 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Journal RSS Feed
Language: English, Croatian
Page range: 121 - 146
Published on: Mar 25, 2010
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Keywords:
chromosome aberrations,
comet assay,
DNA,
micronuclei,
sister chromatid exchanges
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2010 Nevenka Kopjar, Davor Želježić, Vilena Kašuba, Ružica Rozgaj, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.

Volume 61 (2010): Issue 1 (March 2010)
Previous article